NEVE ILAN, Israel, Nov. 25, 2020 (GLOBE NEWSWIRE) — NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Firm”), an modern medical imaging know-how firm, introduced at the moment that the Firm will host a stay demonstration that may showcase the Nanox digital x-ray supply tube and a spread of 2D and 3D imaging functions carried out by the Nanox.ARC on the 2020 Radiology Society of North America Digital Annual Assembly. The stay occasion will happen on the Nanox RSNA digital sales space on Thursday, December 3, 2020 at 11:00am E.T. An investor webinar will comply with the stay occasion on Thursday, December 3, 2020 at 2:00pm E.T.
The investor webinar will characteristic a replay of the recorded RSNA stay steam and shows of medical functions of the Nanox.ARC system by well-known radiologists and their views of how they consider it’ll handle a big unmet want in medical imaging. The webinar can even characteristic an organization presentation by CEO Ran Poliakine adopted by a Q&A session.
“We’re very a lot wanting ahead to debuting the Nanox know-how and imaginative and prescient at this 12 months’s RSNA Annual Assembly, as we consider this novel know-how is poised to considerably increase and democratize the worldwide medical imaging market,” acknowledged Ran Poliakine, Chief Government Officer of Nanox. “Legacy x-ray know-how has developed little since its discovery greater than 120 years in the past, and this analog know-how is just too pricey and complicated for mass deployment. We hope to vary all that and sit up for demonstrating the technological capabilities which may be instrumental in altering the best way we see preventive healthcare by means of mass availability of medical imaging units around the globe.”
Live demonstration at RSNA
Thursday, December 3
events can register for RSNA for a price here.
Thursday, December 3
events could register for the investor webinar here.
Nanox, based by the serial entrepreneur Ran Poliakine, is an Israeli company that’s creating a commercial-grade digital X-ray supply designed for use in real-world medical imaging functions. Nanox believes that its novel know-how might considerably scale back the prices of medical imaging techniques and plans to hunt collaborations with world-leading healthcare organizations and corporations to offer inexpensive, early detection imaging service for all. For extra data, please go to www.nanox.vision.
This press launch could include forward-looking statements which might be topic to dangers and uncertainties. All statements that aren’t historic info contained on this press launch are forward-looking statements. Such statements embrace, however aren’t restricted to, any statements regarding the initiation, timing, progress and outcomes of Nanox’s analysis and growth, manufacturing and commercialization actions with respect to its X-ray supply know-how and the Nanox.Arc. In some instances, you possibly can determine forward-looking statements by terminology equivalent to “can,” “would possibly,” “consider,” “could,” “estimate,” “proceed,” “anticipate,” “intend,” “ought to,” “plan,” “ought to,” “might,” “anticipate,” “predict,” “potential,” or the unfavorable of those phrases or different comparable expressions. Ahead-looking statements are based mostly on data Nanox has when these statements are made or administration’s good religion perception as of that point with respect to future occasions, and are topic to dangers and uncertainties that would trigger precise efficiency or outcomes to vary materially from these expressed in or recommended by the forward-looking statements. Elements that would trigger precise outcomes to vary materially from these at present anticipated embrace: dangers associated to enterprise interruptions ensuing from the COVID-19 pandemic or comparable public well being crises might trigger a disruption of the event, deployment or regulatory clearance of the Nanox System and adversely affect our enterprise; Nanox’s capacity to efficiently reveal the feasibility of its know-how for business functions; Nanox’s expectations concerning the need of, timing of submitting for, and receipt and upkeep of, regulatory clearances or approvals concerning its X-ray supply know-how and the Nanox.Arc from regulatory businesses worldwide and its ongoing compliance with relevant high quality requirements and regulatory necessities; Nanox’s capacity to enter into and keep commercially affordable preparations with third-party producers and suppliers to fabricate the Nanox.Arc; the market acceptance of the Nanox.Arc and the proposed pay-per-scan enterprise mannequin; Nanox’s expectations concerning collaborations with third-parties and their potential advantages; and Nanox’s capacity to conduct enterprise globally, amongst others. Besides as required by regulation, Nanox undertakes no obligation to replace publicly any forward-looking statements after the date of this press launch to evolve these statements to precise outcomes or to modifications in Nanox’s expectations.
ReBlonde for Nanox